Clinical Trial Update: A First Time in Man Study to Asses the Safety and Tolerability of AZD7624 in Healthy Subjects [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study evaluated the safety and tolerability of AZD7624 in healthy subjects and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• AZD7624

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 1 | Status: COMPLETED